Article / Oct 10, 2022
Hovione’s Continuous Manufacturing Facility, Loures, Portugal
Pharmaceutical Technology, 10 October 2022
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Pharmaceutical Technology, 10 October 2022
Manufacturing Chemist, 7 September 2022
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting.